One study showed use of the Aorta-CAD cloud-based software led to a 62 percent reduction of missed aortic calcification that suggested aortic atherosclerosis.
The Food and Drug Administration (FDA) has granted 510(k) clearance to Aorta-CAD (Imagen Technologies), a cloud-based software device which employs deep learning capabilities to help detect aortic atherosclerosis and aortic ectasia on chest X-rays.
Imagen Technologies said the computer-assisted detection (CAD) device creates annotations that alert physicians to findings on chest X-rays that may be indicative of aortic ectasia or atherosclerosis. A clinical trial of the Aorta-CAD device revealed a 35 percent reduction of missed diagnoses for dilated aorta, a finding that suggests aortic ectasia, and a 62 percent reduction of missed diagnoses for aortic calcification, which can be associated with aortic atherosclerosis, according to Imagen Technologies.
“Aorta-CAD assists the physician to have a consistent and repeatable process to look into the cardiac silhouette providing additional information to enhance the patient’s treatment plans and care,” noted Scott Howell, the chief medical officer for Imagen Technologies.
The company adds that Aorta-CAD, which is available through Imagen Technologies’ diagnostics as a service (DaaS) platform, can reportedly be integrated into existing radiology workflows for X-ray reading without costly training or new PACS technology.
AMA Issues 2025 Category III CPT Code for the ECG-Based AI Platform EchoGo Heart Failure
July 2nd 2024The EchoGo Heart Failure platform is reportedly the only AI-powered technology to receive a CPT reimbursement code for echocardiography detection of heart failure with preserved ejection fraction.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.